{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:13:10Z","timestamp":1754154790709,"version":"3.41.2"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YG2023QNA25"],"award-info":[{"award-number":["YG2023QNA25"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24YF2733700"],"award-info":[{"award-number":["24YF2733700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpba.2025.116871","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:07:36Z","timestamp":1743966456000},"page":"116871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessment of the hepatoprotective effects of Bicyclol's forced degradation products using a zebrafish model"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-7393","authenticated-orcid":false,"given":"Mengqi","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xucong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-7225","authenticated-orcid":false,"given":"Guorong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116871_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107308","article-title":"Therapeutic potential of bicyclol in liver diseases: lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine","volume":"91","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpba.2025.116871_bib2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10557-022-07356-6","article-title":"Bicyclol attenuates obesity-induced cardiomyopathy via inhibiting NF-\u03baB and MAPK signaling pathways","volume":"37","author":"Chen","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.jpba.2025.116871_bib3","article-title":"Novel therapies for the treatment of drug-induced liver injury: a systematic review","volume":"12","author":"Beni\u0107","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jpba.2025.116871_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.apsb.2019.01.013","article-title":"Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication","volume":"9","author":"Huang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpba.2025.116871_bib5","first-page":"1803","article-title":"Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug-induced liver injury: A multicenter, randomized, phase II trial","volume":"42","author":"Tang","year":"2022","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jpba.2025.116871_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2020.00463","article-title":"Bicyclol attenuates acute liver injury by activating autophagy, anti-oxidative and anti-inflammatory capabilities in mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jpba.2025.116871_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/0300060514527058","article-title":"Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer","volume":"42","author":"Li","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jpba.2025.116871_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/aps.2009.194","article-title":"Bicyclol protects HepG2 cells against D-galactosamine-induced apoptosis through inducing heat shock protein 27 and mitochondria associated pathway","volume":"31","author":"Bao","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpba.2025.116871_bib9","first-page":"1226","article-title":"Protection by bicyclol derivatives against acetaminophen-induced acute liver failure in mice and its active mechanism","volume":"28","author":"Hou","year":"2008","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jpba.2025.116871_bib10","first-page":"872","article-title":"Mechanism of protective action of bicyclol against CCl-induced liver injury in mice","volume":"25","author":"Liu","year":"2005","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jpba.2025.116871_bib11","article-title":"Comparison and identification of metabolic profiling of bicyclol in rats, dogs and humans in vitro and in vivo","volume":"154","author":"Hu","year":"2020","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.116871_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.lfs.2006.02.025","article-title":"Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action","volume":"79","author":"Hu","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2025.116871_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3748\/wjg.v11.i5.665","article-title":"Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study","volume":"11","author":"Liu","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jpba.2025.116871_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4654","article-title":"Pharmacokinetic analysis of plasma bicyclol by liquid chromatography\u2013tandem mass spectrometry","volume":"33","author":"Liu","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2025.116871_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114947","article-title":"Identification of bicyclol metabolites in rat plasma, urine and feces by UPLC-Q-TOF-MS\/MS and evaluation of the efficacy and safety of these metabolites based on network pharmacology and molecular docking combined with toxicity prediction","volume":"220","author":"Huang","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116871_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/etc.2406","article-title":"Zebrafish as a model system to study toxicology","volume":"33","author":"Dai","year":"2014","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.jpba.2025.116871_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","article-title":"Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials","volume":"20","author":"Patton","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2025.116871_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s12276-021-00571-5","article-title":"Zebrafish as an animal model for biomedical research","volume":"53","author":"Choi","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jpba.2025.116871_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.fsi.2021.11.017","article-title":"Stabilized fermentation product of Cetobacterium somerae improves gut and liver health and antiviral immunity of zebrafish","volume":"120","author":"Xie","year":"2022","journal-title":"FISH SHELLFISH Immunol."},{"key":"10.1016\/j.jpba.2025.116871_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.dci.2007.11.011","article-title":"Immunology and zebrafish: spawning new models of human disease","volume":"32","author":"Meeker","year":"2008","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.jpba.2025.116871_bib21","doi-asserted-by":"crossref","DOI":"10.1289\/EHP11600","article-title":"Assessment of nonalcoholic fatty liver disease symptoms and gut-liver axis status in zebrafish after exposure to polystyrene microplastics and oxytetracycline, alone and in combination","volume":"131","author":"Zhou","year":"2023","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jpba.2025.116871_bib22","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1021\/acs.est.6b00183","article-title":"Uptake and accumulation of polystyrene microplastics in zebrafish (Danio rerio) and toxic effects in liver","volume":"50","author":"Lu","year":"2016","journal-title":"Environ. Sci. Technol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T20:21:53Z","timestamp":1753388513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":22,"alternative-id":["S0731708525002122"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116871","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the hepatoprotective effects of Bicyclol's forced degradation products using a zebrafish model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116871"}}